Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.
about
High-dose toremifene for fulvestrant-resistant metastatic breast cancer: a report of two cases.Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancerHigh-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II studyFulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience.Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
P2860
Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Clinical usefulness of high-do ...... t with an aromatase inhibitor.
@en
Clinical usefulness of high-do ...... t with an aromatase inhibitor.
@nl
type
label
Clinical usefulness of high-do ...... t with an aromatase inhibitor.
@en
Clinical usefulness of high-do ...... t with an aromatase inhibitor.
@nl
prefLabel
Clinical usefulness of high-do ...... t with an aromatase inhibitor.
@en
Clinical usefulness of high-do ...... t with an aromatase inhibitor.
@nl
P2093
P1433
P1476
Clinical usefulness of high-do ...... t with an aromatase inhibitor.
@en
P2093
Hiroko Yamashita
Hirotaka Iwase
Izo Kimijima
Masataka Sawaki
Norikazu Masuda
Shigehira Saji
Takashi Ishikawa
Tohru Ohtake
Yasuo Hozumi
Yoshio Kasahara
P2860
P2888
P304
P356
10.1007/S12282-009-0148-2
P577
2009-08-15T00:00:00Z